Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report

por Madduri, D., Parekh, S., Campbell, T. B., Neumann, F., Petrocca, F., Jagannath, S.
Publicado 2021

P904: CILTACABTAGENE AUTOLEUCEL VS TREATMENTS FROM REAL-WORLD CLINICAL PRACTICE FOR TRIPLE CLASS EXPOSED PATIENTS WITH MULTIPLE MYELOMA: ADJUSTED COMPARISONS BASED ON CARTITUDE-1 A...

por Decaux, O., Hulin, C., Perrot, A., Macro, M., Frenzel, L., Diels, J., Perualila, N. J., Ghilotti, F., Haefliger, B., Goldsztajn, E., Vernet, S., Thevenon, J., Willaime, M., Texier, N., Schecter, J. M., Madduri, D., Jackson, C., Valluri, S., Moreau, P.
Publicado 2022

P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1...

por Lin, Y., Martin, T., Berdeja, J. G., Jakubowiak, A., Agha, M., Cohen, A. D., Deol, A., Htut, M., Lesokhin, A., Munshi, N. C., O’Donnell, E., Jackson, C. C., Yeh, T.-M., Banerjee, A., Zudaire, E., Madduri, D., Zhou, C., Pacaud, L., Usmani, S. Z., Jagannath, S.
Publicado 2022

P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PAT...

por Broijl, A., San-Miguel, J., Suzuki, K., Krishnan, A., van de Donk, N., Cook, G., Jakubowiak, A., Madduri, D., Afifi, S., Stevens, A., Schecter, J., Deraedt, W., Kuppens, S., Mistry, P., Pacaud, L., Boccadoro, M., Gay, F., Mina, R., Rasche, L., Moreau, P., Mateos, M., Einsele, H., Sonneveld, P.
Publicado 2023

B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFT...

por Zweegman, S., Agha, M., Cohen, A.D., Cohen, Y.C., Anguille, S., Kerre, T., Roeloffzen, W., Madduri, D., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Mistry, P., Roccia, T., Xu, X., Li, K., Zudaire, E., Corsale, C., Akram, M., Geng, D., Pacaud, L., Sonneveld, P., van de Donk, N.
Publicado 2023

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B...

por van de Donk, N., Mateos, M.-V., Cohen, Y.C., Rodriguez-Otero, P., Paiva, B., Cohen, A.D., Martin, T., Suvannasankha, A., Madduri, D., Corsale, C., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Deraedt, W., Roccia, T., Mistry, P., Xu, X., Li, K., Zudaire, E., Akram, M., Pacaud, L., Avivi, I., San-Miguel, J.
Publicado 2023